NCT03214666 2022-11-10GTB-3550 Tri-Specific Killer Engager (TriKE®) for High Risk Hematological MalignanciesGT Biopharma, Inc.Phase 1/2 Terminated12 enrolled 20 charts
NCT00726830 2020-09-24Methadone, Morphine, or Oxycodone in Treating Pain in Patients With CancerM.D. Anderson Cancer CenterPhase NA Terminated1 enrolled 3 charts
NCT02415608 2018-09-20Ibrutinib in Treating Patients With Advanced Systemic MastocytosisStanford UniversityPhase 2 Terminated4 enrolled 14 charts
NCT00387426 2014-05-28Sunitinib in Treating Patients With Idiopathic MyelofibrosisNational Cancer Institute (NCI)Phase 2 Terminated14 enrolled 5 charts